Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis

Messenger RNA (mRNA) therapies are emerging in different disease areas, but have not yet reached the kidney field. Our aim was to study the feasibility to treat the genetic defect in cystinosis using synthetic mRNA in cell models and ctns(−/−) zebrafish embryos. Cystinosis is a prototype lysosomal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bondue, Tjessa, Berlingerio, Sante Princiero, Siegerist, Florian, Sendino-Garví, Elena, Schindler, Maximilian, Baelde, Hans Jacobus, Cairoli, Sara, Goffredo, Bianca Maria, Arcolino, Fanny Oliveira, Dieker, Jürgen, Janssen, Manoe Jacoba, Endlich, Nicole, Brock, Roland, Gijsbers, Rik, van den Heuvel, Lambertus, Levtchenko, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684520/
https://www.ncbi.nlm.nih.gov/pubmed/38016974
http://dx.doi.org/10.1038/s41598-023-47085-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684520/
https://www.ncbi.nlm.nih.gov/pubmed/38016974
http://dx.doi.org/10.1038/s41598-023-47085-w

Ejemplares similares